| 000 | 01038 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514060516.0 | ||
| 264 | 0 | _c20030825 | |
| 008 | 200308s 0 0 eng d | ||
| 022 | _a1071-7323 | ||
| 024 | 7 |
_a10.1038/oby.2003.46 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKorner, Judith | |
| 245 | 0 | 0 |
_aTreatment with cabergoline is associated with weight loss in patients with hyperprolactinemia. _h[electronic resource] |
| 260 |
_bObesity research _cFeb 2003 |
||
| 300 |
_a311-2 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAnti-Obesity Agents |
| 650 | 0 | 4 | _aCabergoline |
| 650 | 0 | 4 |
_aErgolines _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperprolactinemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aWeight Loss |
| 700 | 1 | _aLo, Janet | |
| 700 | 1 | _aFreda, Pamela U | |
| 700 | 1 | _aWardlaw, Sharon L | |
| 773 | 0 |
_tObesity research _gvol. 11 _gno. 2 _gp. 311-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/oby.2003.46 _zAvailable from publisher's website |
| 999 |
_c12379722 _d12379722 |
||